FOLR1 and cancer: The high expression of folate receptor alpha (FRα) on the surface of cancer cells and the ability of FRα to transport cytotoxic drugs into cancer cells have led to the development of various therapeutic modalities, including antibodies, antibody–drug conjugates (ADCs), CAR-T, vaccines, small molecules, and folate–drug conjugates [142,143].